Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort DL Rotstein, BC Healy, MT Malik, T Chitnis, HL Weiner JAMA neurology 72 (2), 152-158, 2015 | 465 | 2015 |
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis D Rotstein, X Montalban Nature Reviews Neurology 15 (5), 287-300, 2019 | 277 | 2019 |
Exploration of machine learning techniques in predicting multiple sclerosis disease course Y Zhao, BC Healy, D Rotstein, CRG Guttmann, R Bakshi, HL Weiner, ... PloS one 12 (4), e0174866, 2017 | 193 | 2017 |
Treatment optimization in multiple sclerosis: Canadian MS working group recommendations MS Freedman, V Devonshire, P Duquette, PS Giacomini, F Giuliani, ... Canadian Journal of Neurological Sciences 47 (4), 437-455, 2020 | 105 | 2020 |
Temporal trends in multiple sclerosis prevalence and incidence in a large population DL Rotstein, H Chen, AS Wilton, JC Kwong, RA Marrie, P Gozdyra, ... Neurology 90 (16), e1435-e1441, 2018 | 103 | 2018 |
Phagocytosis of Candida albicans induces apoptosis of human neutrophils D Rotstein, J Parodo, R Taneja, JC Marshall Shock 14 (3), 278-283, 2000 | 89 | 2000 |
Pediatric NMOSD: a review and position statement on approach to work-up and diagnosis S Tenembaum, EA Yeh, ... Frontiers in Pediatrics 8, 339, 2020 | 63 | 2020 |
Effect of vitamin D on MS activity by disease-modifying therapy class DL Rotstein, BC Healy, MT Malik, RL Carruthers, AJ Musallam, P Kivisakk, ... Neuroimmunology & Neuroinflammation 2 (6), e167, 2015 | 63 | 2015 |
Where does the waiting list begin? A short review of the dynamics and organization of modern waiting lists DL Rotstein, DA Alter Social Science & Medicine 62 (12), 3157-3160, 2006 | 49 | 2006 |
Differences between systematic reviews and health technology assessments: A trade-off between the ideals of scientific rigor and the realities of policy making D Rotstein, A Laupacis International Journal of Technology Assessment in Health Care 20 (2), 177-183, 2004 | 48 | 2004 |
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy RL Carruthers, DL Rotstein, BC Healy, T Chitnis, HL Weiner, GJ Buckle Multiple Sclerosis Journal 20 (10), 1381-1390, 2014 | 39 | 2014 |
Diet quality and risk of multiple sclerosis in two cohorts of US women DL Rotstein, M Cortese, TT Fung, T Chitnis, A Ascherio, KL Munger Multiple Sclerosis Journal 25 (13), 1773-1780, 2019 | 38 | 2019 |
Time between expanded disability status scale (EDSS) scores J Zurawski, BI Glanz, A Chua, H Lokhande, D Rotstein, H Weiner, ... Multiple sclerosis and related disorders 30, 98-103, 2019 | 36 | 2019 |
Patterns of care and outcomes after computed tomography scans for headache JJ You, J Gladstone, S Symons, D Rotstein, A Laupacis, CM Bell The American journal of medicine 124 (1), 58-63. e1, 2011 | 36 | 2011 |
MS risk in immigrants in the McDonald era: a population-based study in Ontario, Canada DL Rotstein, RA Marrie, C Maxwell, S Gandhi, SE Schultz, K Fung, K Tu Neurology 93 (24), e2203-e2215, 2019 | 30 | 2019 |
Etiology, effects and management of comorbidities in multiple sclerosis: recent advances RA Marrie, JD Fisk, K Fitzgerald, K Kowalec, C Maxwell, D Rotstein, ... Frontiers in immunology 14, 1197195, 2023 | 29 | 2023 |
Pregnancy and neuromyelitis optica spectrum disorder–Reciprocal effects and practical recommendations: A systematic review R D'Souza, D Wuebbolt, K Andrejevic, R Ashraf, V Nguyen, N Zaffar, ... Frontiers in Neurology 11, 544434, 2020 | 25 | 2020 |
A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course JM Solomon, F Paul, C Chien, J Oh, DL Rotstein Therapeutic Advances in Neurological Disorders 14, 17562864211014389, 2021 | 24 | 2021 |
International delphi consensus on the management of AQP4-IgG+ NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab F Paul, R Marignier, J Palace, G Arrambide, N Asgari, JL Bennett, ... Neurology: Neuroimmunology & Neuroinflammation 10 (4), e200124, 2023 | 22 | 2023 |
Multiple sclerosis fatigue is associated with reduced psychomotor vigilance D Rotstein, P O'Connor, L Lee, BJ Murray Canadian journal of neurological sciences 39 (2), 180-184, 2012 | 22 | 2012 |